|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 22.84 EUR | +2.58% |
|
+3.84% | +8.05% |
| 08:02 | Projekt Nashville: GSK forciert Onkologie-Comeback mit 11 Mrd. USD schwerem Nuvalent-Deal | RE |
| 10.06. | GSK PLC : Intron Health senkt seine Verkaufsbewertung | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.57% | +3.42% | +20.35% | +16.39% | +8.29% | +43.92% | +161.33% | +419.32% | +1’475.60% | 1’013 Mrd. | |
| +0.47% | +4.84% | +8.03% | -1.55% | +15.59% | +54.08% | +49.61% | +45.02% | +104.83% | 574 Mrd. | |
| +0.77% | +0.52% | +11.50% | -0.69% | -1.05% | +18.07% | +64.16% | +95.89% | +277.27% | 397 Mrd. | |
| -0.37% | +4.97% | +3.74% | -2.42% | -0.34% | +21.24% | +15.95% | -4.01% | +30.42% | 324 Mrd. | |
| +0.85% | +0.18% | +0.56% | -6.26% | -1.54% | +24.50% | +14.78% | +62.81% | +254.98% | 280 Mrd. | |
| +2.10% | +4.92% | +6.90% | +0.25% | +10.89% | +25.30% | +33.80% | +45.87% | +61.84% | 273 Mrd. | |
| +5.30% | +2.72% | +7.71% | -6.00% | +8.46% | +21.65% | +63.32% | +46.22% | +131.90% | 182 Mrd. | |
| -0.19% | -0.46% | -5.82% | +13.11% | -13.13% | -45.32% | -48.35% | +9.35% | +55.59% | 194 Mrd. | |
| +4.37% | -2.02% | -5.21% | -13.31% | +3.12% | +15.80% | +62.56% | +84.05% | +50.71% | 151 Mrd. | |
| +2.60% | +2.26% | +1.78% | -3.77% | +5.50% | +7.31% | -34.16% | -34.57% | -24.38% | 146 Mrd. | |
| +2.83% | +0.85% | +2.53% | -4.83% | +5.82% | +13.80% | -11.86% | -15.24% | -20.96% | 114 Mrd. | |
| +2.00% | +0.51% | +2.03% | -9.83% | -2.06% | -1.87% | +30.36% | +130.03% | +390.39% | 111 Mrd. | |
| +0.38% | -0.18% | +4.21% | +0.07% | -7.76% | -12.01% | -19.70% | -14.17% | +9.80% | 105 Mrd. | |
| -1.75% | +0.07% | -5.97% | -21.97% | -9.89% | -2.98% | +87.34% | +74.08% | +484.12% | 77.55 Mrd. | |
| -0.73% | +6.00% | -3.45% | -11.96% | +4.10% | +15.30% | +10.93% | +33.61% | +10.54% | 49.92 Mrd. | |
| -0.06% | -0.47% | -11.02% | -16.92% | -21.13% | -14.78% | +2.60% | -35.64% | +225.49% | 45.92 Mrd. | |
| +1.19% | +0.65% | -3.48% | -10.56% | -3.30% | +28.95% | -29.97% | -33.07% | -59.36% | 40.15 Mrd. | |
| +2.05% | -0.65% | -4.56% | +12.26% | +9.60% | +97.49% | +367.92% | +207.88% | -35.73% | 39.1 Mrd. | |
| -1.21% | +1.27% | +2.11% | -8.82% | -10.89% | -16.14% | +3.94% | - | - | 40.13 Mrd. | |
| Durchschnitt | +1.25% | +2.60% | +1.68% | -4.04% | +0.02% | +15.49% | +43.40% | +62.08% | +190.17% | 218.78 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +1.54% | +3.67% | +7.79% | +1.65% | +4.22% | +25.56% | +63.35% | +135.86% | +458.89% |
- Börse
- Aktien
- A3DMB5 Aktie
- A3DMB5 Aktie
- Sektor GSK plc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
